FTO inhibitor 1 (first disclosed in WO 2018157842) is a novel and potent FTO (fat-mass- and obesity-associated protein) inhibitor with the potential to be used for treatment of leukemia. FTO is overexpressed in certain subtypes of AMLs and promotes leukemogenesis.

纯度：≥98%

CAS：2243736-37-8